GLYC logo

GlycoMimetics (GLYC) Company Overview

Profile

Full Name:

GlycoMimetics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 10, 2014

Indexes:

Not included

Description:

GlycoMimetics is a biotechnology company focused on developing innovative treatments for cancer and other serious diseases. They create drugs that mimic sugars to improve the effectiveness of therapies. Their goal is to enhance patient outcomes through advanced research and targeted therapies.

Events Calendar

Earnings

Next earnings date:

Mar 27, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jul 26, 24 TD Cowen
Hold
Jun 4, 24 HC Wainwright & Co.
Neutral
May 6, 24 HC Wainwright & Co.
Neutral
Mar 27, 24 HC Wainwright & Co.
Buy
Dec 22, 23 Capital One
Overweight
Aug 3, 23 HC Wainwright & Co.
Buy
Jun 15, 23 HC Wainwright & Co.
Buy
May 4, 23 HC Wainwright & Co.
Buy
Mar 30, 23 HC Wainwright & Co.
Buy
Feb 16, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for GlycoMimetics?
  • Does GlycoMimetics pay dividends?
  • What sector is GlycoMimetics in?
  • What industry is GlycoMimetics in?
  • What country is GlycoMimetics based in?
  • When did GlycoMimetics go public?
  • Is GlycoMimetics in the S&P 500?
  • Is GlycoMimetics in the NASDAQ 100?
  • Is GlycoMimetics in the Dow Jones?
  • When was GlycoMimetics's last earnings report?
  • When does GlycoMimetics report earnings?
  • Should I buy GlycoMimetics stock now?

What is the ticker symbol for GlycoMimetics?

The ticker symbol for GlycoMimetics is NASDAQ:GLYC

Does GlycoMimetics pay dividends?

No, GlycoMimetics does not pay dividends

What sector is GlycoMimetics in?

GlycoMimetics is in the Healthcare sector

What industry is GlycoMimetics in?

GlycoMimetics is in the Biotechnology industry

What country is GlycoMimetics based in?

GlycoMimetics is headquartered in United States

When did GlycoMimetics go public?

GlycoMimetics's initial public offering (IPO) was on January 10, 2014

Is GlycoMimetics in the S&P 500?

No, GlycoMimetics is not included in the S&P 500 index

Is GlycoMimetics in the NASDAQ 100?

No, GlycoMimetics is not included in the NASDAQ 100 index

Is GlycoMimetics in the Dow Jones?

No, GlycoMimetics is not included in the Dow Jones index

When was GlycoMimetics's last earnings report?

GlycoMimetics's most recent earnings report was on Nov 13, 2024

When does GlycoMimetics report earnings?

The next expected earnings date for GlycoMimetics is Mar 27, 2025

Should I buy GlycoMimetics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions